Biotech

All Articles

BMS channels TIGIT, bowing out $200M bank on Agenus bispecific

.Bristol Myers Squibb is axing an additional huge bet from the Caforio time, ending a deal for Agenu...

Nuvation standstills BET prevention after looking at stage 1 data

.After taking a look at stage 1 record, Nuvation Biography has actually determined to halt work with...

' Scientific instinct' led FDA experts to support Zevra's uncommon disease med

.Zevra Rehabs' unusual disease drug seems to be on the course to authorization this loss after getti...

Pfizer takes $230M attacked after axing failed DMD gene therapy

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) genetics therapy failure has actually blown a $2...

AC Immune finds 'landmark' potential in Alzheimer's drug records

.After more than 20 years of service neurodegenerative illness, Swiss biotech hvac Immune claims it ...

GSK loses ph. 2 HPV vaccination over shortage of best-in-class possible

.GSK has actually broken up a stage 2 individual papillomavirus (HPV) vaccination coming from its pi...

OS Treatments refiles $6M IPO to finance HER2 medication, preclinical ADCs

.Operating system Therapies will certainly provide on the NYSE American inventory exchange today by ...

ALX's fizzling CD47 reaction rate sends out stock spiraling down

.ALX Oncology's period 2 stomach cancer reaction price has weakened. After seeing its own CD47 block...

Ionis centers eye ailment coming from targets of Roche-partnered possibility after information dissatisfy

.Another of Ionis Pharmaceuticals' key midphase readouts has disappointed assumptions, causing the b...

Biogen's chief executive officer claimed no dangerous sell 2023. He's ready to become strong

.While Biogen's pharma peers are actually hunting for late-stage assets with little bit of risk, chi...